Search clinical trials for: XR-NTX community location

Total 34 results

Michele Staton
National Institute on Drug Abuse (NIDA)

Completed

Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder

Opioid Dependence

United States
Oslo University Hospital

Completed

Baby-Friendly Community Health Services Evaluation

Lactation

Norway
Oregon Health and Science University
Oregon State University; Oregon Department of Corrections; CODA Inc.; Bridgeway... and other collaborators

Completed

Reducing Overdose After Release From Incarceration (ROAR)

Overdose, Drug

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA)

Recruiting

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CURB-2)

Cocaine Use Disorder

United States
University of Washington
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Alkermes, Inc.

Completed

Harm Reduction With Pharmacotherapy (HaRP) (HaRP)

Alcohol Use Disorder

United States
University of California, Los Angeles
Alkermes, Inc.

Completed

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (IPOD)

Opioid Use Disorders

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults

Opioid-use Disorder

United States
Boston University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Alcohol Disorder hOsPital Treatment Trial (ADOPT)

Alcohol Dependence | Alcohol Use Disorder | Heavy Drinking

United States
NYU Langone Health

Completed

Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care (X-ON)

Alcohol Dependence

United States
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
NYU Langone Health
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Opioid Use Disorder (OUD)

United States
New York State Psychiatric Institute

Terminated

Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol

Opioid-use Disorder

United States
San Francisco Department of Public Health
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) (TREX)

Amphetamine-Related Disorders

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR)

Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

Opioid Dependence

United States
NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Alcohol Dependence | Alcohol Use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Naltrexone for Pre-release Prisoners

Opiate Addiction

United States
Massachusetts General Hospital

Recruiting

NTS-WBRT in Brain Metastases

Brain Metastases

United States
Regionshospitalet Viborg, Skive

Completed

Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)

Infertility | Controlled Ovarian Stimulation

Denmark
University of Pennsylvania
Alkermes, Inc.

Recruiting

Naltrexone in AUD Reward Drinkers

Alcoholism | Alcohol Use Disorder

United States
Cingulate Therapeutics

Completed

CTx-1301 Comparative Bioavailability Study

ADHD

United States
University of Oslo
Norwegian Institute of Public Health; Oslo University Hospital; The Research... and other collaborators

Completed

Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway (NTX-SBX)

Opioid Dependence

Norway
Organon and Co

Completed

An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)

Psychosis
Sabine Mueller, MD, PhD
Pacific Pediatric Neuro-Oncology Consortium; Midatech Pharma US Inc.

Completed

MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (PNOC015)

Diffuse Intrinsic Pontine Glioma

United States
University of Cincinnati
National Institute of Mental Health (NIMH)

Completed

Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder (NERF)

Attention Deficit Hyperactivity Disorder

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Not yet recruiting

Emergency Department-Initiated Medications for Alcohol Use Disorder

Alcohol Use Disorder

United States
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR)

Unknown

Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Canada
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

Methamphetamine-dependence | Methamphetamine Abuse
Merck Sharp & Dohme LLC

Active, not recruiting

KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)

Carcinoma, Non-Small-Cell Lung

Poland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
City of Hope Medical Center

Completed

Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
University of Southern California
Veloxis Pharmaceuticals

Recruiting

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR (SIMPLE)

Kidney Transplantation | Kidney Transplant Rejection

United States
Therapeutic Advances in Childhood Leukemia Consortium
Abbott

Terminated

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Acute Lymphoblastic Leukemia | Relapsed Pediatric ALL | Recurrent Pediatric ALL | Refractory Pediatric ALL

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Chronic Myelomonocytic Leukemia | Childhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Myeloblastic... and other conditions

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Recruiting

Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States

Search clinical trials for: XR-NTX community location

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations